185 related articles for article (PubMed ID: 30856332)
1. Optimization of Peptidomimetics as Selective Inhibitors for the β-Catenin/T-Cell Factor Protein-Protein Interaction.
Wang Z; Zhang M; Wang J; Ji H
J Med Chem; 2019 Apr; 62(7):3617-3635. PubMed ID: 30856332
[TBL] [Abstract][Full Text] [Related]
2. Targeting the Tcf4 G13ANDE17 binding site to selectively disrupt β-catenin/T-cell factor protein-protein interactions.
Huang Z; Zhang M; Burton SD; Katsakhyan LN; Ji H
ACS Chem Biol; 2014 Jan; 9(1):193-201. PubMed ID: 24191653
[TBL] [Abstract][Full Text] [Related]
3. Discovery of Selective Small-Molecule Inhibitors for the β-Catenin/T-Cell Factor Protein-Protein Interaction through the Optimization of the Acyl Hydrazone Moiety.
Catrow JL; Zhang Y; Zhang M; Ji H
J Med Chem; 2015 Jun; 58(11):4678-92. PubMed ID: 25985283
[TBL] [Abstract][Full Text] [Related]
4. Ku70 and poly(ADP-ribose) polymerase-1 competitively regulate beta-catenin and T-cell factor-4-mediated gene transactivation: possible linkage of DNA damage recognition and Wnt signaling.
Idogawa M; Masutani M; Shitashige M; Honda K; Tokino T; Shinomura Y; Imai K; Hirohashi S; Yamada T
Cancer Res; 2007 Feb; 67(3):911-8. PubMed ID: 17283121
[TBL] [Abstract][Full Text] [Related]
5. Wnt signaling inside the nucleus.
Shitashige M; Hirohashi S; Yamada T
Cancer Sci; 2008 Apr; 99(4):631-7. PubMed ID: 18177486
[TBL] [Abstract][Full Text] [Related]
6. Investigation of 3-aryl-pyrimido[5,4-e][1,2,4]triazine-5,7-diones as small molecule antagonists of β-catenin/TCF transcription.
Zeller J; Turbiak AJ; Powelson IA; Lee S; Sun D; Showalter HD; Fearon ER
Bioorg Med Chem Lett; 2013 Nov; 23(21):5814-20. PubMed ID: 24060489
[TBL] [Abstract][Full Text] [Related]
7. Functional interaction of DNA topoisomerase IIalpha with the beta-catenin and T-cell factor-4 complex.
Huang L; Shitashige M; Satow R; Honda K; Ono M; Yun J; Tomida A; Tsuruo T; Hirohashi S; Yamada T
Gastroenterology; 2007 Nov; 133(5):1569-78. PubMed ID: 17983804
[TBL] [Abstract][Full Text] [Related]
8. Discovery of 2-(3-(3-Carbamoylpiperidin-1-yl)phenoxy)acetic Acid Derivatives as Novel Small-Molecule Inhibitors of the β-Catenin/B-Cell Lymphoma 9 Protein-Protein Interaction.
Wang Z; Zhang M; Luo W; Zhang Y; Ji H
J Med Chem; 2021 May; 64(9):5886-5904. PubMed ID: 33902288
[TBL] [Abstract][Full Text] [Related]
9. Structure-Based Optimization of Small-Molecule Inhibitors for the β-Catenin/B-Cell Lymphoma 9 Protein-Protein Interaction.
Zhang M; Wang Z; Zhang Y; Guo W; Ji H
J Med Chem; 2018 Apr; 61(7):2989-3007. PubMed ID: 29566337
[TBL] [Abstract][Full Text] [Related]
10. Chromosomal instability by beta-catenin/TCF transcription in APC or beta-catenin mutant cells.
Aoki K; Aoki M; Sugai M; Harada N; Miyoshi H; Tsukamoto T; Mizoshita T; Tatematsu M; Seno H; Chiba T; Oshima M; Hsieh CL; Taketo MM
Oncogene; 2007 May; 26(24):3511-20. PubMed ID: 17160019
[TBL] [Abstract][Full Text] [Related]
11. Rational design of small-molecule inhibitors for β-catenin/T-cell factor protein-protein interactions by bioisostere replacement.
Yu B; Huang Z; Zhang M; Dillard DR; Ji H
ACS Chem Biol; 2013 Mar; 8(3):524-9. PubMed ID: 23272635
[TBL] [Abstract][Full Text] [Related]
12. The β-catenin/TCF complex as a novel target of resveratrol in the Wnt/β-catenin signaling pathway.
Chen HJ; Hsu LS; Shia YT; Lin MW; Lin CM
Biochem Pharmacol; 2012 Nov; 84(9):1143-53. PubMed ID: 22935447
[TBL] [Abstract][Full Text] [Related]
13. Salinomycin exerts anti-colorectal cancer activity by targeting the β-catenin/T-cell factor complex.
Wang Z; Zhou L; Xiong Y; Yu S; Li H; Fan J; Li F; Su Z; Song J; Sun Q; Liu SS; Xia Y; Zhao L; Li S; Guo F; Huang P; Carson DA; Lu D
Br J Pharmacol; 2019 Sep; 176(17):3390-3406. PubMed ID: 31236922
[TBL] [Abstract][Full Text] [Related]
14. Identification of SP5 as a downstream gene of the beta-catenin/Tcf pathway and its enhanced expression in human colon cancer.
Takahashi M; Nakamura Y; Obama K; Furukawa Y
Int J Oncol; 2005 Dec; 27(6):1483-7. PubMed ID: 16273202
[TBL] [Abstract][Full Text] [Related]
15. New homogeneous high-throughput assays for inhibitors of β-catenin/Tcf protein-protein interactions.
Zhang M; Huang Z; Yu B; Ji H
Anal Biochem; 2012 May; 424(1):57-63. PubMed ID: 22370279
[TBL] [Abstract][Full Text] [Related]
16. Sox17 and Sox4 differentially regulate beta-catenin/T-cell factor activity and proliferation of colon carcinoma cells.
Sinner D; Kordich JJ; Spence JR; Opoka R; Rankin S; Lin SC; Jonatan D; Zorn AM; Wells JM
Mol Cell Biol; 2007 Nov; 27(22):7802-15. PubMed ID: 17875931
[TBL] [Abstract][Full Text] [Related]
17. Nucleo-cytoplasmic shuttling of APC can maximize β-catenin/TCF concentration.
Schmitz Y; Wolkenhauer O; Rateitschak K
J Theor Biol; 2011 Jun; 279(1):132-42. PubMed ID: 21439299
[TBL] [Abstract][Full Text] [Related]
18. 2,4-Diamino-quinazolines as inhibitors of beta-catenin/Tcf-4 pathway: Potential treatment for colorectal cancer.
Chen Z; Venkatesan AM; Dehnhardt CM; Dos Santos O; Delos Santos E; Ayral-Kaloustian S; Chen L; Geng Y; Arndt KT; Lucas J; Chaudhary I; Mansour TS
Bioorg Med Chem Lett; 2009 Sep; 19(17):4980-3. PubMed ID: 19640711
[TBL] [Abstract][Full Text] [Related]
19. Interaction of nuclear receptors with the Wnt/beta-catenin/Tcf signaling axis: Wnt you like to know?
Mulholland DJ; Dedhar S; Coetzee GA; Nelson CC
Endocr Rev; 2005 Dec; 26(7):898-915. PubMed ID: 16126938
[TBL] [Abstract][Full Text] [Related]
20. Ionomycin downregulates beta-catenin/Tcf signaling in colon cancer cell line.
Park CH; Hahm ER; Lee JH; Jung KC; Rhee HS; Yang CH
Carcinogenesis; 2005 Nov; 26(11):1929-33. PubMed ID: 15930030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]